Analysis of Key Stakeholders in the National Drug Centralized Procurement Policy
- VernacularTitle:国家药品集中采购政策的主要利益相关者分析
- Author:
Jinping XIE
1
;
Xuerui ZHANG
1
;
He ZHANG
1
;
Yifan YANG
1
;
Rong SHAO
1
Author Information
1. Institute of Drug Regulatory Science，China Pharmaceutical University/NMPA Key Laboratory for Drug Regulatory Innovation and Evaluation，Nanjing 211198，China
- Publication Type:Journal Article
- Keywords:
National Drug Centralized Procurement Policy;
Stakeholders;
Government department;
Pharmaceutical enterprise
- From:
China Pharmacy
2021;32(21):2677-2682
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE：To provide reference for the better implementation of National Drug Centralized Procurement Policy （hereinafter referred to as the“National Centralized Procurement Policy”）. METHODS：Based on the stakeholder theory， combining with literature research and interview research methods，the role orientation，interest demands and mutual relations of the main stakeholders involved in National Centralized Procurement Policy，such as government departments，pharmaceutical enterprises，medical institutions and patients were analyzed. RESULTS & CONCLUSIONS：Government departments include medical insurance department，health department，drug supervision department and other departments，which plan and lead the National Centralized Procurement Policy；their main interest demand is to ensure the orderly implementation of the policy，the rational use and supply guarantee of the selected varieties in clinic，etc. Pharmaceutical enterprises include pharmaceutical production enterprises and pharmaceutical circulation enterprises，which directly participate in the National Centralized Procurement Policy； the main interest demand of drug production enterprises is to ensure reasonable profits to support their product R&D and promote enterprise transformation；that of pharmaceutical circulation enterprises is to obtain the variety distribution right， so as to improve the market share of enterprises，expand the breadth and depth of marketing，and obtain operating profits，etc. As the main provider of medical services and drugs， medical institutions are responsible for implementing the selected category results of the National Centralized Procurement Policy；their main interest demand is to improve its own popularity and reputation. Patients are not only the demanders of medical services and drugs，but also the main beneficiaries of the reform of National Centralized Procurement Policy；their main interest demand is to reduce the drug burden and ensure that the drugs used are safe and effective. In order to better promote the National Centralized Procurement Policy，it is suggested to give play to the leading role of the government and promote the reform of“tripartite system reform”in coordination with other policies；optimize the drug procurement mechanism and guide the reasonable formation of market price；encourage enterprises to continuously improve the quality of varieties through generic drug consistency evaluation，and strengthen quality supervision.
